EMA Calls For Visual Warnings Among Measures To Restrict Valproate Use

The European Medicines Agency has recommended that EU member states should introduce further restrictions on the use of valproate-containing medicines to avoid the drug's exposure in pregnancy.

Pregnancy
Restrictions Aim To Avoid Exposure To Valproate Medicines In Pregnancy • Source: Shutterstock

The European Medicines Agency's pharmacovigilance committee, PRAC, has recommended further restrictions to avoid exposure of babies in the womb to valproate-containing medicines, which are used to treat epilepsy, bipolar disorder and migraine.

The recommendations, which include a call to introduce a pregnancy prevention program, apply to the use of valproate medicines in...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Drug Safety

More from Pink Sheet